- Healthcare Professionals
- Patients and Caregivers
- Administration (Materials Management)
- Library (Downloads & Videos)
What is HeRO Graft?
Quality of Life
Compared to catheters, HeRO Graft has:
- 69% fewer infections1
- 16% to 32% improved dialysis clearance of toxins and fluids (Kt/V)1
- Less than half the interventions to keep access functioning1
- Patency rates comparable to AVG2
HeRO Graft (Hemodialysis Reliable Outflow) is the ONLY fully subcutaneous AV access solution clinically proven to maintain long-term access for hemodialysis patients with central venous stenosis. HeRO Graft is classified by the FDA as a graft, but differs from a conventional AV graft since it has no venous anastomosis. It consists of two primary components:
A proprietary ePTFE Arterial Graft Component
The HeRO Graft Arterial Graft Component has a 6mm inner diameter (ID), 7.4mm outer diameter (OD), and is 53cm long, inclusive of the connector. It consists of an ePTFE hemodialysis graft with PTFE beading to provide kink resistance near the proprietary titanium connector. The titanium connector attaches the Arterial Graft Component to the Venous Outflow Component. The Arterial Graft Component is cannulated using standard technique according to KDOQI guidelines.
A proprietary Venous Outflow Component
The HeRO Graft Venous Outflow Component has a 5mm ID, 19F (6.3mm) OD, and is 40cm long. It consists of radiopaque silicone with braided nitinol reinforcement (for kink and crush resistance) and a radiopaque marker band at the distal tip.
Is HeRO Graft for you?
The HeRO Graft may be right for you if you are:
- Failing your fistula or graft
- Fewer Infections: 69% reduced infection rate compared with catheters1
- Superior Dialysis Adequacy: 1.7 Kt/V, a 16% to 32% improvement compared with catheters1
- High Patency Rates: Up to 87% cumulative patency at 2 years1,2
- Cost Savings: A 23% average savings per year compared with catheters3
HeRO Graft may be the ideal solution for:
- Salvaging a failing fistula due to central venous stenosis
- Salvaging a failing AV graft due to central venous stenosis
- Converting a catheter-dependent patient
- Patients unable to achieve blood flow rates prescribed by their Doctor
- Patients unable to reach target Kt/V clearances during dialysis (KDOQI target clearances, Kt/V=1.4)
- Katzman et al., J Vasc Surg, 2009; Comparisons to catheters are from literature review on file.
- Gage et al., EJVES 2012.
- Dageforde et al., JSR 2012.